ANTIBODY CLASS AND SUBCLASS RESPONSES TO PNEUMOCOCCAL POLYSACCHARIDES FOLLOWING IMMUNIZATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

被引:68
作者
CARSON, PJ
SCHUT, RL
SIMPSON, ML
OBRIEN, J
JANOFF, EN
机构
[1] UNIV MINNESOTA,VA MED CTR,SCH MED,DEPT MED,INFECT DIS SECT 111F,MINNEAPOLIS,MN 55417
[2] HENNEPIN CTY MED CTR,MINNEAPOLIS,MN
关键词
D O I
10.1093/infdis/172.2.340
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies of the IgM class and IgG2 and IgA2 subclasses are prominent in responses to pneumococcal polysaccharides (PPS) but may be decreased in human immunodeficiency virus (HIV)-infected patients, among whom invasive pneumococcal disease is common. After immunization of HIV-infected and -seronegative subjects with pneumococcal vaccine, the number of PPS-specific antibody-secreting cells (ASC) producing IgM was significantly lower among HIV-infected subjects, whereas PPS-specific IgG and IgA ASC were more comparable. The subclass distribution of PPS-specific IgG2-producing (similar to 80%) and IgA2-producing (similar to 50%) ASC and antibodies in serum were similar. However, before immunization, the proportions of PPS-specific IgG2 for both serotypes 8 and 14 in baseline sera from HIV-infected patients were significantly decreased compared with controls. Thus, the response to PPS among HIV-infected patients may be characterized by lower levels of specific IgG2 before immunization and prominent defects in IgM responses soon after stimulation.
引用
收藏
页码:340 / 345
页数:6
相关论文
共 39 条
[1]   CORRELATION BETWEEN G2M(N) IMMUNOGLOBULIN ALLOTYPE AND HUMAN-ANTIBODY RESPONSE AND SUSCEPTIBILITY TO POLYSACCHARIDE ENCAPSULATED BACTERIA [J].
AMBROSINO, DM ;
SCHIFFMAN, G ;
GOTSCHLICH, EC ;
SCHUR, PH ;
ROSENBERG, GA ;
DELANGE, GG ;
VANLOGHEM, E ;
SIBER, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (06) :1935-1942
[2]  
AMMAN AJ, 1981, JAMA-J AM MED ASSOC, V251, P1447
[3]   ANTIBODIES TO PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION GIVEN POLYVALENT PNEUMOCOCCAL VACCINE [J].
ARPADI, SM ;
BACK, S ;
OBRIEN, J ;
JANOFF, EN .
JOURNAL OF PEDIATRICS, 1994, 125 (01) :77-79
[4]  
AUCOUTURIER P, 1986, CLIN EXP IMMUNOL, V63, P234
[5]   PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA [J].
AUSTRIAN, R ;
GOLD, J .
ANNALS OF INTERNAL MEDICINE, 1964, 60 (05) :759-+
[6]  
BAKER PJ, 1981, REV INFECT DIS, V3, P332
[7]   COMPARISON OF THE INDUCTION OF IMMUNOGLOBULIN-M AND IMMUNOGLOBULIN-G ANTIBODIES IN MICE WITH PURIFIED PNEUMOCOCCAL TYPE-3 AND MENINGOCOCCAL GROUP-C POLYSACCHARIDES AND THEIR PROTEIN CONJUGATES [J].
BEUVERY, EC ;
VANROSSUM, F ;
NAGEL, J .
INFECTION AND IMMUNITY, 1982, 37 (01) :15-22
[8]   TYPE-SPECIFIC ANTIPNEUMOCOCCAL ANTIBODIES IN A VACCINATED PATIENT WITH COMBINED IMMUNOGLOBULIN A AND IGG2 DEFICIENCY AND INVASIVE PNEUMOCOCCAL INFECTIONS [J].
BRUYN, GAW ;
HIEMSTRA, PS ;
RIJKERS, GT .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) :1460-1461
[9]   IMMUNOGLOBULIN-G CLASS AND SUBCLASS ANTIBODIES TO PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES [J].
CHUDWIN, DS ;
ARTRIP, SG ;
SCHIFFMAN, G .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 44 (01) :114-121